{"log_id": 5000700756004007117, "direction": 0, "words_result_num": 59, "words_result": [{"probability": {"variance": 1e-06, "average": 0.999177, "min": 0.997608}, "location": {"width": 581, "top": 80, "height": 78, "left": 312}, "words": "注射用福莫司汀说明书"}, {"probability": {"variance": 0, "average": 0.999839, "min": 0.999268}, "location": {"width": 115, "top": 157, "height": 25, "left": 106}, "words": "【药品名称】"}, {"probability": {"variance": 0.006868, "average": 0.963924, "min": 0.643438}, "location": {"width": 492, "top": 131, "height": 65, "left": 418}, "words": "请仔细阅读说明书并在医师指导下使用制约为"}, {"probability": {"variance": 1e-06, "average": 0.998892, "min": 0.996641}, "location": {"width": 248, "top": 185, "height": 26, "left": 142}, "words": "通用名称:注射用福莫司汀"}, {"probability": {"variance": 0.031416, "average": 0.926282, "min": 0.492153}, "location": {"width": 122, "top": 210, "height": 26, "left": 141}, "words": "英文名称:Fo"}, {"probability": {"variance": 0.00049, "average": 0.931089, "min": 0.908964}, "location": {"width": 62, "top": 219, "height": 20, "left": 352}, "words": " for Inje"}, {"probability": {"variance": 0.001457, "average": 0.983726, "min": 0.883162}, "location": {"width": 136, "top": 239, "height": 24, "left": 138}, "words": "汉语拼音:Zhu"}, {"probability": {"variance": 0, "average": 0.704935, "min": 0.704935}, "location": {"width": 59, "top": 226, "height": 76, "left": 737}, "words": "蚍"}, {"probability": {"variance": 0, "average": 0.785909, "min": 0.785909}, "location": {"width": 68, "top": 207, "height": 72, "left": 804}, "words": "★"}, {"probability": {"variance": 3e-06, "average": 0.998566, "min": 0.993359}, "location": {"width": 306, "top": 263, "height": 33, "left": 104}, "words": "【成份】本品主要成份为福莫司汀"}, {"probability": {"variance": 0.003162, "average": 0.970166, "min": 0.750864}, "location": {"width": 574, "top": 290, "height": 40, "left": 139}, "words": "化学名称:(±)二乙基[1-[3-(2-氯乙基)-3-亚硝基脲]乙基]磷酸酯"}, {"probability": {"variance": 0, "average": 0.999656, "min": 0.998772}, "location": {"width": 109, "top": 319, "height": 24, "left": 138}, "words": "化学结构式"}, {"probability": {"variance": 0.021895, "average": 0.923676, "min": 0.408522}, "location": {"width": 208, "top": 422, "height": 24, "left": 136}, "words": "分子式:CH19ClN3O5P"}, {"probability": {"variance": 0.008171, "average": 0.966353, "min": 0.69595}, "location": {"width": 137, "top": 450, "height": 24, "left": 138}, "words": "分子量:315.69"}, {"probability": {"variance": 2e-06, "average": 0.998692, "min": 0.996794}, "location": {"width": 72, "top": 473, "height": 24, "left": 101}, "words": "【性状】"}, {"probability": {"variance": 2e-06, "average": 0.999024, "min": 0.994255}, "location": {"width": 644, "top": 497, "height": 42, "left": 137}, "words": "本品为淡黄色结晶性粉末。注射用溶剂为无色透明液体,具有乙醇气味"}, {"probability": {"variance": 2e-06, "average": 0.999024, "min": 0.99657}, "location": {"width": 92, "top": 523, "height": 23, "left": 99}, "words": "【适应症】"}, {"probability": {"variance": 1.1e-05, "average": 0.998686, "min": 0.983783}, "location": {"width": 616, "top": 547, "height": 41, "left": 132}, "words": "用于治疗原发性恶性脑肿瘤和播散性恶性黑色素瘤(包括脑内部位)"}, {"probability": {"variance": 0, "average": 0.999613, "min": 0.999187}, "location": {"width": 72, "top": 571, "height": 26, "left": 98}, "words": "【规格】"}, {"probability": {"variance": 1.2e-05, "average": 0.996647, "min": 0.989881}, "location": {"width": 51, "top": 603, "height": 22, "left": 137}, "words": "208mg"}, {"probability": {"variance": 1.5e-05, "average": 0.99656, "min": 0.988674}, "location": {"width": 111, "top": 627, "height": 23, "left": 98}, "words": "【用法用量】"}, {"probability": {"variance": 1e-06, "average": 0.999203, "min": 0.995425}, "location": {"width": 920, "top": 651, "height": 49, "left": 132}, "words": "在使用前立即配制溶液。溶液一经配制应立即使用,必须在避光条件下给予;静脉输注控制在1小时内"}, {"probability": {"variance": 0.000524, "average": 0.993745, "min": 0.864093}, "location": {"width": 1008, "top": 678, "height": 52, "left": 131}, "words": "用4ml安瓿瓶内的无菌乙醇溶液将福莫司汀瓶中的内容物溶解,然后计算好用药剂量,将溶液用250ml5%等渗葡"}, {"probability": {"variance": 4e-06, "average": 0.998662, "min": 0.992772}, "location": {"width": 252, "top": 706, "height": 30, "left": 89}, "words": "萄糖稀释后,用于静脉输注"}, {"probability": {"variance": 4e-06, "average": 0.998372, "min": 0.994246}, "location": {"width": 201, "top": 735, "height": 24, "left": 134}, "words": "1、单一药剂化疗包括"}, {"probability": {"variance": 3e-06, "average": 0.999018, "min": 0.992893}, "location": {"width": 490, "top": 760, "height": 36, "left": 165}, "words": "1)诱导治疗:每周一次连续三次后,停止用药4~5周"}, {"probability": {"variance": 1e-06, "average": 0.999295, "min": 0.99767}, "location": {"width": 283, "top": 788, "height": 33, "left": 164}, "words": "2)维持治疗:每三周治疗一次"}, {"probability": {"variance": 0.017198, "average": 0.959691, "min": 0.505592}, "location": {"width": 198, "top": 817, "height": 32, "left": 163}, "words": "通常使用剂量100mg/m"}, {"probability": {"variance": 1.4e-05, "average": 0.997748, "min": 0.98541}, "location": {"width": 585, "top": 844, "height": 43, "left": 134}, "words": "2、联合化疗:去掉诱导治疗中的第三次给药,剂量维持100mg/m"}, {"probability": {"variance": 0, "average": 0.999761, "min": 0.99949}, "location": {"width": 113, "top": 873, "height": 23, "left": 92}, "words": "【不良反应】"}, {"probability": {"variance": 0.002167, "average": 0.991937, "min": 0.65371}, "location": {"width": 988, "top": 899, "height": 49, "left": 132}, "words": "1.不良反应主要是对血液学方面的影响,表现为血小板减少(40.3%)和白细胞减少(46.3%),发生时间较晚"}, {"probability": {"variance": 6e-06, "average": 0.998631, "min": 0.987766}, "location": {"width": 495, "top": 926, "height": 35, "left": 85}, "words": "最低水平分别在首剂诱导治疗后的4~5周和5~6周出现"}, {"probability": {"variance": 1.4e-05, "average": 0.998691, "min": 0.973531}, "location": {"width": 997, "top": 952, "height": 53, "left": 130}, "words": "若在注射用福莫司汀治疗前,进行过化学治疗及或本品与其它可以诱导造血毒性的药物联合应用时,会增加血"}, {"probability": {"variance": 0, "average": 0.999667, "min": 0.998232}, "location": {"width": 166, "top": 981, "height": 25, "left": 84}, "words": "液系统的不良反应"}, {"probability": {"variance": 3.6e-05, "average": 0.99725, "min": 0.973477}, "location": {"width": 999, "top": 1006, "height": 51, "left": 128}, "words": "2常见中度恶心及呕吐(46.7%),多出现注射后2小时内。此外见于氨基转移酶、碱性磷酸酶和血胆红素有中度"}, {"probability": {"variance": 0.000198, "average": 0.994966, "min": 0.938311}, "location": {"width": 330, "top": 1034, "height": 32, "left": 84}, "words": "的、暂时性、可逆性的增高(29.5%)"}, {"probability": {"variance": 0.0014, "average": 0.988717, "min": 0.764655}, "location": {"width": 683, "top": 1062, "height": 42, "left": 127}, "words": "3.少见的不良反应有发热(3.3%)、注射部位静脉炎(2.9%)、腹泻(2.6%"}, {"probability": {"variance": 0, "average": 0.999927, "min": 0.999927}, "location": {"width": 23, "top": 1091, "height": 25, "left": 84}, "words": "加"}, {"probability": {"variance": 2.5e-05, "average": 0.997342, "min": 0.981429}, "location": {"width": 273, "top": 1079, "height": 35, "left": 850}, "words": "腹痛(1.3%)、尿素暂时性增"}, {"probability": {"variance": 0.00036, "average": 0.995319, "min": 0.866919}, "location": {"width": 906, "top": 1092, "height": 47, "left": 152}, "words": "%)、瘙痒(0.7%)、暂时性、可逆性的神经功能障碍(意识障碍、感觉异常、失味症)(0.7%)等"}, {"probability": {"variance": 0, "average": 0.999972, "min": 0.999932}, "location": {"width": 70, "top": 1146, "height": 23, "left": 89}, "words": "【禁忌】"}, {"probability": {"variance": 1e-05, "average": 0.998589, "min": 0.978278}, "location": {"width": 975, "top": 1117, "height": 52, "left": 149}, "words": "与达卡巴嗪联合应用时(参见药物的相互作用),观察到有极少发生的肺毒性(急性成年人呼吸抑制综合症)"}, {"probability": {"variance": 0.000153, "average": 0.995588, "min": 0.958506}, "location": {"width": 202, "top": 1172, "height": 25, "left": 130}, "words": "1怀孕期及哺乳期妇女"}, {"probability": {"variance": 0.00498, "average": 0.986602, "min": 0.564733}, "location": {"width": 733, "top": 1196, "height": 46, "left": 125}, "words": "2.禁用于合并使用黄热病疫苗和采用苯妥英作为预防治疗(见药物的相互作用);"}, {"probability": {"variance": 0, "average": 0.999417, "min": 0.997978}, "location": {"width": 372, "top": 1227, "height": 32, "left": 126}, "words": "3本品通常不推荐与减毒活疫苗联合使用"}, {"probability": {"variance": 0, "average": 0.999914, "min": 0.999814}, "location": {"width": 112, "top": 1253, "height": 25, "left": 87}, "words": "【注意事项】"}, {"probability": {"variance": 0.000752, "average": 0.994325, "min": 0.823415}, "location": {"width": 786, "top": 1278, "height": 45, "left": 123}, "words": "1.不推荐将本品用于过去4周内接受过化疗(或6周内用过亚硝基脲类药物治疗)的患者"}, {"probability": {"variance": 7e-06, "average": 0.998237, "min": 0.988682}, "location": {"width": 496, "top": 1307, "height": 38, "left": 125}, "words": "2只有患者在血小板和或粒细胞计数分别等于或大于10"}, {"probability": {"variance": 0, "average": 0.999555, "min": 0.999555}, "location": {"width": 19, "top": 1326, "height": 18, "left": 728}, "words": "和"}, {"probability": {"variance": 0.002453, "average": 0.982835, "min": 0.818942}, "location": {"width": 227, "top": 1326, "height": 30, "left": 831}, "words": "m3的情况才考虑使用本品"}, {"probability": {"variance": 2e-06, "average": 0.999289, "min": 0.992459}, "location": {"width": 783, "top": 1336, "height": 45, "left": 143}, "words": "每次新给药前,均须进行血细胞计数,并根据血液学状态调整用药剂量。下表可作指导"}, {"probability": {"variance": 0, "average": 0.999768, "min": 0.999644}, "location": {"width": 61, "top": 1380, "height": 20, "left": 243}, "words": "血小板"}, {"probability": {"variance": 6e-06, "average": 0.996496, "min": 0.994501}, "location": {"width": 59, "top": 1385, "height": 21, "left": 490}, "words": "粒细胞"}, {"probability": {"variance": 2.1e-05, "average": 0.99679, "min": 0.986168}, "location": {"width": 142, "top": 1390, "height": 24, "left": 710}, "words": "给药剂量百分数"}, {"probability": {"variance": 0.000201, "average": 0.98439, "min": 0.970207}, "location": {"width": 21, "top": 1481, "height": 18, "left": 781}, "words": ")%"}, {"probability": {"variance": 0, "average": 0.999882, "min": 0.999705}, "location": {"width": 81, "top": 1507, "height": 24, "left": 742}, "words": "推迟治疗"}, {"probability": {"variance": 0.001088, "average": 0.993281, "min": 0.781022}, "location": {"width": 971, "top": 1535, "height": 52, "left": 112}, "words": "4.建议从诱导治疗开始和维持治疗开始之间,推荐的间隔期是8周,每两次维持治疗周期之间,间隔期是3周"}, {"probability": {"variance": 0.005028, "average": 0.978428, "min": 0.685929}, "location": {"width": 492, "top": 1566, "height": 37, "left": 113}, "words": "5.只有在血小板计数和/或粒性白细胞计数分别达到100"}, {"probability": {"variance": 0.007318, "average": 0.968893, "min": 0.617826}, "location": {"width": 350, "top": 1580, "height": 35, "left": 698}, "words": "和2,000/mm3时,才考虑进行维持治疗"}], "language": 3}